Top 18 Signostics investors
The most complete profiles first. Showing 18 of 18.
Ingmar WahlqvistVerified
Venture Capital, Investor · Australia
SeedHealth CareLife ScienceEducationBiotechnologyPortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
Mara MacdonaldVerified
Venture Capital, Private Equity Firm, Investor · Australia
SeedHealth CareLife ScienceEducationBiotechnologyPortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
Melissa ByrneVerified
Venture Capital, Investor · Australia
SeedHealth CareLife ScienceEducationBiotechnologyPortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
Michael BettessVerified
Venture Capital, Private Equity Firm, Investor · Australia
SeedHealth CareLife ScienceBiotechnologyHealth and Hospital ServicesPortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
Darren KellyVerified
Venture Capital · Australia
Health CareLife ScienceBiotechnologyNeurosciencePortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
David FisherVerified
Venture Capital, Private Equity Firm · Australia
Health CareLife ScienceBiotechnologyNeurosciencePortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
Johannes HuthVerified
Private Equity Firm · United Kingdom
Health CareTelecommunicationsE-commerceCRMPortfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more
Verified email available
Joseph BaeVerified
Private Equity Firm · Hong Kong
Health CareTelecommunicationsE-commerceCRMPortfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more
Verified email available
Mattia CaprioliVerified
Private Equity Firm · United Kingdom
Health CareTelecommunicationsE-commerceCRMPortfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more
Verified email available
Ming LuVerified
Venture Capital, Private Equity Firm, Finance Operator
Health CareTelecommunicationsE-commerceEnterprise SoftwarePortfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more
Verified email available
Raj AgrawalVerified
Venture Capital, Private Equity Firm, Finance Operator · United States
Health CareTelecommunicationsE-commerceEnterprise SoftwarePortfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more
Verified email available
Stephen ThompsonVerified
Venture Capital · Australia
Health CareLife ScienceBiotechnologyNeurosciencePortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Verified email available
Suzanne DonohoeVerified
Private Equity Firm · United States
Health CareTelecommunicationsE-commerceCRMPortfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more
Verified email available
Melissa McBurnie
Venture Capital, Private Equity Firm, Investor · Australia
SeedHealth CareLife ScienceBiotechnologyHealth and Hospital ServicesPortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Contact details available
Shane CheekVerified
Angel/Individual · Australia
AdvertisingHealth CareEnterprise SoftwareTransportationPortfolio: MoveitNet, Optimatics, Embertec, TCPinpoint and 4 more
Verified email available
Brandon Freiman
Venture Capital, Private Equity Firm, Finance Operator · United States
Health CareTelecommunicationsE-commerceEnterprise SoftwarePortfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more
Contact details available
Kerensa Argyriou
Venture Capital · Australia
Health CareLife ScienceBiotechnologyNeurosciencePortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Contact details available
Leighton Read
Venture Capital, Private Equity Firm · United States
Health CareLife ScienceBiotechnologyNeurosciencePortfolio: QUE Oncology, Elastagen, Denteric, MecRx and 20 more
Contact details available
By investment stage
- Seed5
By location
Related industries
Most-backed portfolio companies
- Okogen10
- EBR Systems10
- OccuRx10
- MetaBloQ10
- Aravax10
- MecRx10
- Global Kinetics Corporation10
- Spinifex Pharmaceuticals10
- Vaxxas10
- QUE Oncology10
- G I Therapies10
Frequently asked questions
How many Signostics investors are on Angel Roster?
Angel Roster lists 18 Signostics investors. 14 of them (78%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (13), Private Equity Firms (12) and Finance Operator Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Signostics investors invest in?
Among those that list a stage, the most common are Seed (5).
Where are Signostics investors based?
Most are based in Australia (10), the United States (4) and the United Kingdom (2).
Which companies have Signostics investors backed?
The most-backed portfolio companies among them are Okogen (10), EBR Systems (10), OccuRx (10), MetaBloQ (10) and Aravax (10).
How do I contact Signostics investors?
Create a free Angel Roster account to search and filter all 18, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.